Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation
- 17 April 2007
- journal article
- clinical trial
- Published by Elsevier in Immunology Letters
- Vol. 110 (1) , 54-64
- https://doi.org/10.1016/j.imlet.2007.03.004
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblastsRheumatology, 2005
- Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritisArthritis & Rheumatism, 2005
- Evolving concepts of rheumatoid arthritisNature, 2003
- Interleukin 1 Receptor Dependence of Serum Transferred Arthritis Can be Circumvented by Toll-like Receptor 4 SignalingThe Journal of Experimental Medicine, 2003
- HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal PathwayJournal of Biological Chemistry, 2002
- Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritidesArthritis & Rheumatism, 2000
- Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritisArthritis & Rheumatism, 2000
- Activated T Lymphocytes Support Osteoclast Formation in VitroBiochemical and Biophysical Research Communications, 1999
- A New Mechanism of Bone Destruction in Rheumatoid Arthritis: Synovial Fibroblasts Induce OsteoclastogenesisBiochemical and Biophysical Research Communications, 1997
- Rheumatoid ArthritisNew England Journal of Medicine, 1990